Literature DB >> 17708623

Ganodermataceae: natural products and their related pharmacological functions.

Xuanwei Zhou1, Juan Lin, Yizhou Yin, Jingya Zhao, Xiaofen Sun, Kexuan Tang.   

Abstract

The objective of this paper is to review the natural products and the pharmacological functions of Ganodermataceae family. Presently, studies on the bioactive components of Lingzhi are focused on polysaccharides and triterpenes/triterpenoids compounds. New Ganoderma polysaccharides, including their molecular weights, glycosyl residue compositions, glycosyl linkage and branches, are summarized in this paper. Also presented are new types of triterpenes and their characteristics from Lingzhi. Taking Ganoderma lucidum as an example, we reviewed its pharmacological functions in anti-tumor and immune-modulating activities for treating hypoglycemosis, hepatoprotection, and the effect on blood vessel system. Based on the advances in Lingzhi research in the past few decades, both G. lucidum and G. sinense are considered as the representative species of medicinal mushroom Lingzhi in China. Until 2001, G. tsugae was only advised to be used as the materials of the health products. The biologically-active components related to pharmacological functions of these three species were studied more than other Ganodermataceae family species; however, which have been used in less modern folk medicine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17708623     DOI: 10.1142/S0192415X07005065

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  21 in total

Review 1.  Natural compounds for pediatric cancer treatment.

Authors:  Veronica Ferrucci; Iolanda Boffa; Gina De Masi; Massimo Zollo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-12-09       Impact factor: 3.000

2.  TRAIL pathway is associated with inhibition of colon cancer by protopanaxadiol.

Authors:  Zhiyu Zhang; Zejuan Li; Xiaohui Wu; Chun-Feng Zhang; Tyler Calway; Tong-Chuan He; Wei Du; Jianjun Chen; Chong-Zhi Wang; Chun-Su Yuan
Journal:  J Pharmacol Sci       Date:  2014-11-18       Impact factor: 3.337

3.  Antidepressant-like effect of Ganoderma lucidum spore polysaccharide-peptide mediated by upregulation of prefrontal cortex brain-derived neurotrophic factor.

Authors:  Shuang Zhao; Chengbo Rong; Yi Gao; Linfeng Wu; Xiaoheng Luo; Shuang Song; Yu Liu; Jack Ho Wong; Hexiang Wang; Litao Yi; Tzibun Ng
Journal:  Appl Microbiol Biotechnol       Date:  2021-10-30       Impact factor: 4.813

4.  Effects on tyrosinase activity by the extracts of Ganoderma lucidum and related mushrooms.

Authors:  Chih-Ching Chien; Mei-Ling Tsai; Chin-Chu Chen; Shing-Jyh Chang; Ching-Hui Tseng
Journal:  Mycopathologia       Date:  2008-05-06       Impact factor: 2.574

5.  Potential role of ginseng in the treatment of colorectal cancer.

Authors:  Chong-Zhi Wang; Chun-Su Yuan
Journal:  Am J Chin Med       Date:  2008       Impact factor: 4.667

6.  Deep insight into the Ganoderma lucidum by comprehensive analysis of its transcriptome.

Authors:  Guo-Jun Yu; Man Wang; Jie Huang; Ya-Lin Yin; Yi-Jie Chen; Shuai Jiang; Yan-Xia Jin; Xian-Qing Lan; Barry Hon Cheung Wong; Yi Liang; Hui Sun
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

7.  Optimizing a culture medium for biomass and phenolic compounds production using Ganoderma lucidum.

Authors:  Carlos Andrés Zárate-Chaves; María Camila Romero-Rodríguez; Fabián Camilo Niño-Arias; Jorge Robles-Camargo; Melva Linares-Linares; María Ximena Rodríguez-Bocanegra; Ivonne Gutiérrez-Rojas
Journal:  Braz J Microbiol       Date:  2013-05-17       Impact factor: 2.476

8.  Ganoderma tsugae Extract Inhibits Growth of HER2-Overexpressing Cancer Cells via Modulation of HER2/PI3K/Akt Signaling Pathway.

Authors:  Han-Peng Kuo; Shih-Chung Hsu; Chien-Chih Ou; Jhy-Wei Li; Hsiu-Hsueh Tseng; Tzu-Chao Chuang; Jah-Yao Liu; Shih-Jung Chen; Muh-Hwan Su; Yung-Chi Cheng; Wei-Yuan Chou; Ming-Ching Kao
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-07       Impact factor: 2.629

9.  Ganoderma tsugae Induces S Phase Arrest and Apoptosis in Doxorubicin-Resistant Lung Adenocarcinoma H23/0.3 Cells via Modulation of the PI3K/Akt Signaling Pathway.

Authors:  Yang-Hao Yu; Han-Peng Kuo; Hui-Hsia Hsieh; Jhy-Wei Li; Wu-Huei Hsu; Shih-Jung Chen; Muh-Hwan Su; Shwu-Huey Liu; Yung-Chi Cheng; Chih-Yi Chen; Ming-Ching Kao
Journal:  Evid Based Complement Alternat Med       Date:  2012-06-26       Impact factor: 2.629

10.  Evaluation of anti-microbial activity of spore powder of Ganoderma lucidum on clinical isolates of Prevotella intermedia: A pilot study.

Authors:  Ranganath N Nayak; P T Dixitraj; Aarati Nayak; Kishore Bhat
Journal:  Contemp Clin Dent       Date:  2015-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.